Trial Profile
A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre, Pan-Asian Trial Comparing the Efficacy and Safety of FE 999049 With Follitropin Alfa (GONAL-F) in Controlled Ovarian Stimulation in Women Undergoing Assisted Reproductive Technology Programme
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Aug 2023
Price :
$35
*
At a glance
- Drugs Follitropin delta (Primary) ; Follitropin alfa
- Indications Female infertility
- Focus Registrational; Therapeutic Use
- Acronyms GRAPE
- Sponsors Ferring Pharmaceuticals
- 29 Jun 2021 Results published in the Ferring Pharmaceuticals Media Release.
- 29 Jun 2021 According to a Ferring Pharmaceuticals media release, data from this study were presented today at the 37th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE).
- 28 May 2021 Status changed from active, no longer recruiting to completed.